Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

A new method accurately measures DHEAS in blood, improving on current tests.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Lower testosterone levels may increase heart failure risk in older men.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Eating dairy and high glycemic foods may increase the risk of acne.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.